{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:29:46Z","timestamp":1791422986039,"version":"4.3.3"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241726-4\"><jats:title>Importance<\/jats:title><jats:p>Electroconvulsive therapy (ECT) practice during the COVID-19 pandemic necessitated restriction of bag-valve mask (BVM) ventilation to minimize disease transmission through aerosolization. To reduce BVM use, many sites decreased doses of anesthesia agents, but the associations of such dose reduction with clinical and tolerability outcomes are unknown.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-5\"><jats:title>Objectives<\/jats:title><jats:p>To investigate the association of COVID-19 pandemic modifications in ECT, including reduction in anesthetic dosage and BVM use, with the rates of clinical complications and clinical outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective cohort study included data from patients receiving an index course of ECT for any clinical indication treated with methohexital and succinylcholine between March 16, 2017, and March 15, 2023, at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. Data analysis occurred from February to December 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-7\"><jats:title>Exposure<\/jats:title><jats:p>Participants were split into 2 cohorts: pre\u2013COVID-19 (treated between March 2017 and March 2020) and COVID-19 (treated between June 2020 and March 2023).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcomes were BVM use and rates of complications (specifically, aspiration, bradycardia, insufficient initial sedation dosage, postictal agitation [PIA], residual weakness, and prolonged seizures). Secondary outcomes were rates of response and cognitive impairment. Multivariable logistic regression was used to assess associations of COVID-19 pandemic modifications with outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-9\"><jats:title>Results<\/jats:title><jats:p>A total of 616 individuals (median [IQR] age, 45.0 [31.0-59.0] years; 342 female [55.5%]) were included in the analysis, with 362 in the pre-COVID-19 group and 254 in the COVID-19 group. Demographic and clinical characteristics were similar. The COVID-19 group received lower median (IQR) methohexital dosages (0.82 [0.72-0.96] mg\/kg vs 0.87 [0.78-1.00] mg\/kg; <jats:italic>P<\/jats:italic>\u2009=\u2009.007) and succinylcholine (0.33 [0.27-0.39] mg\/kg vs 0.53 [0.45-0.59] mg\/kg; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) than the pre\u2013COVID-19 group. The COVID-19 group had higher odds of insufficient initial sedation dosage (odds ratio, 2.16, 95% CI, 1.09-4.38) and PIA (odds ratio, 2.81; 95% CI, 1.76-4.56), with no difference for other complications. BVM use was reduced from standard use to 13.8% (35 individuals) during COVID-19. Groups were similar in the rates of response (pre\u2013COVID-19, 246 individuals [68.0%]; COVID-19, 181 individuals [71.3%]; <jats:italic>P<\/jats:italic>\u2009=\u2009.38) and cognitive impairment (pre\u2013COVID-19, 75 individuals [20.7%]; COVID-19, 49 individuals [19.3%]; <jats:italic>P<\/jats:italic>\u2009=\u2009.66).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241726-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this retrospective cohort study, reduction of anesthesia agents was associated with reduced BVM use, with similar clinical outcomes and tolerability other than increased rates of insufficient initial sedation dosage and PIA, suggesting that management of PIA with this anesthesia dosing strategy warrants further investigation.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.62054","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:33:04Z","timestamp":1740673984000},"page":"e2462054","source":"Crossref","is-referenced-by-count":7,"title":["Tolerability and Clinical Outcomes With Anesthesia Dose Reduction During Electroconvulsive Therapy"],"prefix":"10.1001","volume":"8","author":[{"given":"Caroline W.","family":"Espinola","sequence":"first","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Kaster","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Prillo","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorina","family":"Zapf","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Foley","sequence":"additional","affiliation":[{"name":"Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology and Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ma","sequence":"additional","affiliation":[{"name":"Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology and Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Van Rensburg","sequence":"additional","affiliation":[{"name":"Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology and Pain Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Blumberger","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"2","key":"zoi241726r1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/YCT.0000000000000690","article-title":"Electroconvulsive therapy in a time of coronavirus disease.","volume":"36","author":"Tor","year":"2020","journal-title":"J ECT"},{"issue":"7","key":"zoi241726r2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jagp.2020.04.013","article-title":"Electroconvulsive therapy during COVID-19-times: our patients cannot wait.","volume":"28","author":"Sienaert","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"zoi241726r3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/YCT.0000000000000689","article-title":"Electroconvulsive therapy during COVID-19: an essential medical procedure-maintaining service viability and accessibility.","volume":"36","author":"Espinoza","year":"2020","journal-title":"J ECT"},{"issue":"5","key":"zoi241726r4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/S1092852921000110","article-title":"Electroconvulsive therapy: still the gold standard for highly treatment-resistant mood disorders.","volume":"27","author":"Goldberg","year":"2022","journal-title":"CNS Spectr"},{"issue":"8","key":"zoi241726r5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamapsychiatry.2017.1670","article-title":"Modern electroconvulsive therapy: vastly improved yet greatly underused.","volume":"74","author":"Sackeim","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"zoi241726r6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000509113","article-title":"Modified anesthesia protocol for electroconvulsive therapy permits reduction in aerosol-generating bag-mask ventilation during the COVID-19 pandemic.","volume":"89","author":"Luccarelli","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"3","key":"zoi241726r7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/YCT.0000000000000707","article-title":"Uninterrupted anesthesia support and technique adaptations for patients presenting for electroconvulsive therapy during the COVID-19 era.","volume":"36","author":"Thiruvenkatarajan","year":"2020","journal-title":"J ECT"},{"key":"zoi241726r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102653","article-title":"Electroconvulsive therapy services during COVID-19 pandemic.","volume":"59","author":"Surve","year":"2021","journal-title":"Asian J Psychiatr"},{"issue":"3","key":"zoi241726r9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/YCT.0000000000000702","article-title":"A strategy for management of electroconvulsive therapy patients during the COVID-19 pandemic.","volume":"36","author":"Bryson","year":"2020","journal-title":"J ECT"},{"issue":"3","key":"zoi241726r10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1192\/bjb.2021.43","article-title":"Effects of the COVID-19 pandemic on provision of electroconvulsive therapy.","volume":"46","author":"Braithwaite","year":"2022","journal-title":"BJPsych Bull"},{"issue":"1","key":"zoi241726r11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/YCT.0000000000000801","article-title":"Electroconvulsive therapy in Canada during the first wave of COVID-19: results of the \u201cwhat happened\u201d national survey.","volume":"38","author":"Demchenko","year":"2022","journal-title":"J ECT"},{"issue":"11","key":"zoi241726r12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jagp.2020.08.001","article-title":"Electroconvulsive therapy practice changes in older individuals due to COVID-19: expert consensus statement.","volume":"28","author":"Lapid","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"zoi241726r13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/YCT.0000000000000800","article-title":"The Impact of COVID-19 on electroconvulsive therapy: a multisite, retrospective study from the clinical alliance and research in electroconvulsive therapy and related treatments network.","volume":"38","author":"Kwan","year":"2022","journal-title":"J ECT"},{"issue":"3","key":"zoi241726r14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/YCT.0000000000000705","article-title":"General anesthesia recommendations for electroconvulsive therapy during the coronavirus disease 2019 pandemic.","volume":"36","author":"Limoncelli","year":"2020","journal-title":"J ECT"},{"key":"zoi241726r16","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e2056","article-title":"Electroconvulsive therapy practice during the COVID-19 pandemic.","volume":"75","author":"Bellini","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"issue":"6","key":"zoi241726r17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/bjaceaccp\/mkq039","article-title":"Anaesthesia for electroconvulsive therapy.","volume":"10","author":"Uppal","year":"2010","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"issue":"2","key":"zoi241726r18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00124509-200006000-00007","article-title":"Anesthesia for electroconvulsive therapy: a review.","volume":"16","author":"Folk","year":"2000","journal-title":"J ECT"},{"issue":"4","key":"zoi241726r19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1039856218761301","article-title":"Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy.","volume":"26","author":"Bryson","year":"2018","journal-title":"Australas Psychiatry"},{"issue":"3","key":"zoi241726r20","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1097\/YCT.0b013e3182503bc9","article-title":"Methohexital and succinylcholine dosing for electroconvulsive therapy (ECT): actual versus ideal.","volume":"28","author":"Bryson","year":"2012","journal-title":"J ECT"},{"issue":"2","key":"zoi241726r21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","article-title":"Clinical practice guidelines for the use of electroconvulsive therapy.","volume":"65","author":"Thirthalli","year":"2023","journal-title":"Indian J Psychiatry"},{"issue":"7","key":"zoi241726r22","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice.","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"4","key":"zoi241726r24","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.4088\/JCP.16m10686","article-title":"Clinical effectiveness and cognitive impact of electroconvulsive therapy for schizophrenia: a large retrospective study.","volume":"78","author":"Kaster","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zoi241726r25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00406-010-0173-3","article-title":"Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas.","volume":"261","author":"Kristensen","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"zoi241726r28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/00000542-200510000-00027","article-title":"Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials.","volume":"103","author":"Schreiber","year":"2005","journal-title":"Anesthesiology"},{"issue":"11","key":"zoi241726r29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1213\/00000539-198611000-00016","article-title":"Comparison of propofol with methohexital for outpatient anesthesia.","volume":"65","author":"Doze","year":"1986","journal-title":"Anesth Analg"},{"issue":"3","key":"zoi241726r30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/YCT.0000000000000886","article-title":"Acute and prophylactic management of postictal agitation in electroconvulsive therapy.","volume":"39","author":"Sterina","year":"2023","journal-title":"J ECT"},{"issue":"5","key":"zoi241726r31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001785","article-title":"Evaluation of the self-inflating bag-valve-mask and non-rebreather mask as preoxygenation devices in volunteers.","volume":"2","author":"Robinson","year":"2012","journal-title":"BMJ Open"},{"issue":"1","key":"zoi241726r32","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/762053","article-title":"From mouth-to-mouth to bag-valve-mask ventilation: evolution and characteristics of actual devices\u2013a review of the literature.","volume":"2014","author":"Khoury","year":"2014","journal-title":"Biomed Res Int"},{"issue":"3","key":"zoi241726r33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40140-022-00527-z","article-title":"Airway management during cardiopulmonary resuscitation.","volume":"12","author":"Mohamed","year":"2022","journal-title":"Curr Anesthesiol Rep"},{"issue":"7","key":"zoi241726r34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00005053-199007000-00007","article-title":"Electroconvulsive therapy emergence agitation and succinylcholine dose.","volume":"178","author":"Swartz","year":"1990","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"zoi241726r35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/YCT.0b013e3182887b5b","article-title":"Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.","volume":"29","author":"Tzabazis","year":"2013","journal-title":"J ECT"},{"issue":"1","key":"zoi241726r36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/YCT.0000000000000866","article-title":"Severe postictal confusion after electroconvulsive therapy: a retrospective study.","volume":"39","author":"Schuur","year":"2023","journal-title":"J ECT"},{"issue":"2","key":"zoi241726r37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1440-1819.2009.01930.x","article-title":"Identification of predictors of post-ictal delirium after electroconvulsive therapy.","volume":"63","author":"Kikuchi","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"zoi241726r38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/YCT.0000000000000891","article-title":"Postanesthesia recovery unit optimization for patients with postictal agitation secondary to electroconvulsive therapy.","volume":"39","author":"Arora","year":"2023","journal-title":"J ECT"},{"issue":"5","key":"zoi241726r39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0163-8343(93)90028-M","article-title":"ECT emergence agitation and methohexital-succinylcholine interaction. Case report.","volume":"15","author":"Swartz","year":"1993","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi241726r40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1170931","article-title":"Pharmacological prevention of postictal agitation after electroconvulsive therapy-A systematic review and meta-analysis.","volume":"14","author":"Feenstra","year":"2023","journal-title":"Front Psychiatry"},{"issue":"3","key":"zoi241726r41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00124509-200009000-00007","article-title":"Post-ECT agitation and plasma lactate concentrations.","volume":"16","author":"Auriacombe","year":"2000","journal-title":"J ECT"},{"issue":"6","key":"zoi241726r42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11920-008-0076-4","article-title":"Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician.","volume":"10","author":"Cristancho","year":"2008","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"zoi241726r43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00124509-200212000-00009","article-title":"Clinical approach to agitation after electroconvulsive therapy: a case report and literature review.","volume":"18","author":"Augoustides","year":"2002","journal-title":"J ECT"},{"issue":"2","key":"zoi241726r44","first-page":"140","article-title":"Clinical features and predictors of postictal excitement.","volume":"5","author":"Devanand","year":"1989","journal-title":"Convuls Ther"},{"issue":"1","key":"zoi241726r45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/da.20048","article-title":"Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.","volume":"21","author":"Bailey","year":"2005","journal-title":"Depress Anxiety"},{"issue":"4","key":"zoi241726r46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.","volume":"65","author":"Husain","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"zoi241726r47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors.","volume":"76","author":"Haq","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"zoi241726r48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis.","volume":"212","author":"van Diermen","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"1","key":"zoi241726r49","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgaa019","article-title":"Predictors of treatment response to electroconvulsive therapy in schizophrenia\u2014a nationwide registry-based study.","volume":"1","author":"Stenmark","year":"2020","journal-title":"Schizophr Bull Open"},{"issue":"1","key":"zoi241726r50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brs.2017.10.009","article-title":"Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: a matched retrospective cohort study.","volume":"11","author":"Kaster","year":"2018","journal-title":"Brain Stimul"},{"issue":"2","key":"zoi241726r51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/schbul\/sbaa144","article-title":"Treatment capacity and clinical outcomes for patients with schizophrenia who were treated with electroconvulsive therapy: a retrospective cohort study.","volume":"47","author":"Plahouras","year":"2021","journal-title":"Schizophr Bull"},{"issue":"7","key":"zoi241726r52","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy.","volume":"386","author":"Espinoza","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi241726r53","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jagp.2016.02.053","article-title":"Systematic review of cognitive effects of electroconvulsive therapy in late-life depression.","volume":"24","author":"Kumar","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"zoi241726r54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1192\/bjp.bp.109.066183","article-title":"Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.","volume":"196","author":"Kellner","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"Pt A","key":"zoi241726r55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109150","article-title":"Alcohol and other substance use during the COVID-19 pandemic: A systematic review.","volume":"a29","author":"Roberts","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi241726r56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/YCT.0000000000000807","article-title":"Factors associated with postictal agitation after electroconvulsive therapy.","volume":"38","author":"Allen","year":"2022","journal-title":"J ECT"},{"issue":"1","key":"zoi241726r57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brs.2015.09.005","article-title":"The anaesthetic-ECT time interval in electroconvulsive therapy practice\u2013is it time to time?","volume":"9","author":"G\u00e1lvez","year":"2016","journal-title":"Brain Stimul"},{"key":"zoi241726r58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jad.2021.02.038","article-title":"Association of anaesthesia-ECT time interval with ECT clinical outcomes: a retrospective cohort study.","volume":"285","author":"Tan","year":"2021","journal-title":"J Affect Disord"},{"key":"zoi241726r23","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"zoi241726r26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-1-4377-2207-9.00004-5","volume-title":"Evidence-Based Physical Diagnosis","author":"McGee","year":"2012","edition":"3rd ed"},{"key":"zoi241726r15","unstructured":"International Society for ECT and Neurostimulation (ISEN). Position statement on ECT as an essential procedure during COVID-19. Published December 8, 2020. Accessed January 21, 2025. https:\/\/www.isen-ect.org\/covid-19-essential-procedure"},{"key":"zoi241726r27","unstructured":"The R Foundation. R: a language and environment for statistical computing. Accessed January 17, 2025. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2830784\/espinola_2025_oi_241726_1739997146.01378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:33:10Z","timestamp":1740673990000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2830784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.62054","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}